Literature DB >> 11292588

Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated.

C S Chung1, W Wang, I H Chaudry, A Ayala.   

Abstract

Recent studies from our laboratory demonstrated that mucosal lymphoid tissue such as Peyer's patch cells and lamina propria (LP) B lymphocytes from mice shows evidence of increased apoptosis after sepsis that is associated with localized inflammation/activation. The mechanism for this is poorly understood. Endotoxin as well as Fas/Fas ligand (FasL) have been shown to augment lymphocyte apoptosis; however, their contribution to the increase of apoptosis in LP B-cells during sepsis is not known. To study this, sepsis was induced by cecal ligation and puncture (CLP) in endotoxin-tolerant C3H/HeJ or FasL-deficient C3H/HeJ-FasL(gld) (FasL(-)) mice and LP lymphocytes were isolated 24 h later. Phenotypic, apoptotic, and functional indexes were assessed. The number of LP B cells decreased markedly in C3H/HeJ mice but not in FasL-deficient animals at 24 h after CLP. This was associated with comparable alteration in apoptosis and Fas antigen expression in the B cells of these mice. Septic LP lymphocytes also showed increased IgA production, which was absent in the FasL-deficient CLP mice. Furthermore, Fas ligand deficiency appeared to improve survival of septic challenge. These data suggest that the increase in B cell apoptosis in septic animals is partially due to a Fas/FasL-mediated process but not endotoxin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292588     DOI: 10.1152/ajpgi.2001.280.5.G812

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  14 in total

Review 1.  Mechanisms of immune resolution.

Authors:  Alfred Ayala; Chun-Shiang Chung; Patricia S Grutkoski; Grace Y Song
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

2.  Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer's patch and the liver at an early stage after bile duct ligation in mice.

Authors:  A Ogawa; T Tagawa; H Nishimura; T Yajima; T Abe; T Arai; M Taniguchi; K Takeda; S Akira; Y Nimura; Y Yoshikai
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

Review 3.  Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness.

Authors:  Jessica A Clark; Craig M Coopersmith
Journal:  Shock       Date:  2007-10       Impact factor: 3.454

4.  Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality.

Authors:  Amy C Fox; Elise R Breed; Zhe Liang; Andrew T Clark; Brendan R Zee-Cheng; Katherine C Chang; Jessica A Dominguez; Enjae Jung; W Michael Dunne; Eileen M Burd; Alton B Farris; David C Linehan; Craig M Coopersmith
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

5.  PATHOLOGICAL ASPECTS OF THE ANTI-INFLAMMATORY/IMMUNE SUPPRESSIVE RESPONSE IN SEPSIS AND SHOCK.

Authors:  Alfred Ayala; Yanli Ding; Rebecca J Rhee; Lesley A Doughty; Patrician S Grutkoski; Chun-Shiang Chung
Journal:  Rec Res Dev Immunol       Date:  2003-01-12

6.  Sepsis: prognostic role of apoptosis regulators in gastrointestinal cells.

Authors:  Evangelos Messaris; Panagiotis Kekis; Nicolaos Memos; Emmy Chatzigianni; Evangelos Menenakos; Emanuel Leandros; Manousos M Konstadoulakis
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

7.  Iron dysregulation combined with aging prevents sepsis-induced apoptosis.

Authors:  Pardis Javadi; Timothy G Buchman; Paul E Stromberg; Isaiah R Turnbull; Dinesh Vyas; Richard S Hotchkiss; Irene E Karl; Craig M Coopersmith
Journal:  J Surg Res       Date:  2005-09       Impact factor: 2.192

Review 8.  The apoptotic pathway as a therapeutic target in sepsis.

Authors:  Doreen E Wesche-Soldato; Ryan Z Swan; Chun-Shiang Chung; Alfred Ayala
Journal:  Curr Drug Targets       Date:  2007-04       Impact factor: 3.465

9.  CD8+ T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL.

Authors:  Doreen E Wesche-Soldato; Chun-Shiang Chung; Stephen H Gregory; Thais P Salazar-Mather; Carol A Ayala; Alfred Ayala
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

10.  VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis.

Authors:  Peter Weber; Ping Wang; Stephane Maddens; Paul Sh Wang; Rongqian Wu; Michael Miksa; Weifeng Dong; Michael Mortimore; Julian M C Golec; Peter Charlton
Journal:  Crit Care       Date:  2009-09-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.